Patents by Inventor Daniel POLLYEA

Daniel POLLYEA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220136068
    Abstract: The present disclosure relates to methods of identifying AML patients who will be resistant to venetoclax therapy and methods of treating venetoclax-resistant patients with myeloid leukemia cell differentiation protein (MCL-1) inhibitors.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 5, 2022
    Inventors: Clayton SMITH, Craig T. JORDAN, Daniel POLLYEA, Shanshan PEI